Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
Opinion|Videos|August 5, 2024

Financial Challenges of BTK Inhibitor Therapy in CLL: Impact on Access and Utilization

Experts discuss financial challenges of BTK inhibitor therapy.

Episodes in this series

Video content above is prompted by the following question(s):

  1. What are the financial burdens of BTK inhibitor therapy? How does the cost of BTK inhibitors impact access and utilization for patients with CLL?

Related Content